Table 2.
Clinic features of theTG and non-TG groups at thetime of biopsy
| Clinic features | TG (n = 43) | non-TG(n = 43) | P value |
|---|---|---|---|
| Proteinuria (g/24 h) |
2.01 ± 1.60 |
0.89 ± 0.96 |
0.001 |
| Patients with proteinuria |
40 (93.0%) |
20 (46.5%) |
<0.001 |
| <1 g/24 h |
10 (23.3%) |
9 (20.9%) |
0.565 |
| 1-3.5 g/24 h |
22 (51.2%) |
10 (23.2%) |
0.007 |
| >3.5 g/24 h |
8 (18.6%) |
1 (2.3%) |
0.014 |
| Hematuria |
13 (30.2%) |
5 (11.6%) |
0.034 |
| Hemoglobin (g/dl) |
9.48 ± 2.18 |
10.66 ± 2.01 |
0.011 |
| Patients with anemia |
37 (86.0%) |
28 (65.1%) |
0.022 |
| Mild (9-12 g/dl) |
17 (39.5%) |
18 (41.9%) |
0.500 |
| Moderate (6-9 g/dl) |
18 (41.9%) |
10 (23.3%) |
0.050 |
| Severe (<6 g/dl) |
2 (4.7%) |
0 |
0.247 |
| Albumin (g/L) |
33.79 ± 4.89 |
39.50 ± 4.48 |
0.330 |
| Hypoalbuminemia |
26 (60.5%) |
5 (11.6%) |
<0.001 |
| Creatinine (mg/dl)* |
2.12 ± 1.26 |
2.00 ± 1.02 |
0.600 |
| Patients with the history of rejection |
15 (34.9%) |
14 (32.6%) |
0.943 |
| HCV infection |
15 (34.9%) |
3 (7.0%) |
0.003 |
| HLA-I antibodies present |
9/30(30%) |
1/23 (4.3%) |
0.018 |
| HLA-II antibodies present | 17/30 (56.7%) | 4/23 (17.4%) | 0.004 |
Data are presented as mean ± SD or number of cases. *Creatinine compared in TG group had excluded 3 dialysis patients.